The Biology of T Regulatory Type 1 Cells and Their Therapeutic Application in Immune-Mediated Diseases

Immunity

Volumn 49, Issue 6, 2018, Pages 1004-1019

  Roncarolo, Maria Grazia ^a   Gregori, Silvia ^b   Bacchetta, Rosa ^a   Battaglia, Manuela ^c   Gagliani, Nicola ^d,e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN SPECIFICITY; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T REGULATORY TYPE 1 CELL; ANIMAL; AUTOIMMUNE DISEASE; BIOLOGICAL MODEL; BIOLOGICAL THERAPY; IMMUNOLOGY; METABOLISM; PROCEDURES; TRANSPLANTATION;

ANIMALS; ANTIGENS; AUTOIMMUNE DISEASES; CELL- AND TISSUE-BASED THERAPY; CYTOKINES; HUMANS; MODELS, IMMUNOLOGICAL; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, REGULATORY;

EID: 85058183708     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2018.12.001     Document Type: Review

References (145)

1. Abbas, A.K., Benoist, C., Bluestone, J.A., Campbell, D.J., Ghosh, S., Hori, S., Jiang, S., Kuchroo, V.K., Mathis, D., Roncarolo, M.G., et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat. Immunol. 14 (2013), 307–308.
2. Akdis, M., Verhagen, J., Taylor, A., Karamloo, F., Karagiannidis, C., Crameri, R., Thunberg, S., Deniz, G., Valenta, R., Fiebig, H., et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 199 (2004), 1567–1575.
3. Alfen, J.S., Larghi, P., Facciotti, F., Gagliani, N., Bosotti, R., Paroni, M., Maglie, S., Gruarin, P., Vasco, C.M., Ranzani, V., et al. Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease. J. Allergy Clin. Immunol. 142 (2018), 1537–1547.e8.
4. Alhadj Ali, M., Liu, Y.F., Arif, S., Tatovic, D., Shariff, H., Gibson, V.B., Yusuf, N., Baptista, R., Eichmann, M., Petrov, N., et al. Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes. Sci. Transl. Med., 9, 2017, eaaf7779.
5. Amodio, G., Gregori, S., Human tolerogenic DC-10: perspectives for clinical applications. Transplant. Res., 1, 2012, 14.
6. Amodio, G., Comi, M., Tomasoni, D., Gianolini, M.E., Rizzo, R., LeMaoult, J., Roncarolo, M.G., Gregori, S., HLA-G expression levels influence the tolerogenic activity of human DC-10. Haematologica 100 (2015), 548–557.
7. Anderson, A.C., Joller, N., Kuchroo, V.K., Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation. Immunity 44 (2016), 989–1004.
8. Andolfi, G., Fousteri, G., Rossetti, M., Magnani, C.F., Jofra, T., Locafaro, G., Bondanza, A., Gregori, S., Roncarolo, M.G., Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells. Mol. Ther. 20 (2012), 1778–1790.
9. Andreani, M., Gianolini, M.E., Testi, M., Battarra, M., Tiziana, G., Morrone, A., Sodani, P., Lucarelli, G., Roncarolo, M.G., Gregori, S., Mixed chimerism evolution is associated with T regulatory type 1 (Tr1) cells in a β-thalassemic patient after haploidentical haematopoietic stem cell transplantation. Chimerism 5 (2014), 75–79.
10. Arif, S., Tree, T.I., Astill, T.P., Tremble, J.M., Bishop, A.J., Dayan, C.M., Roep, B.O., Peakman, M., Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 113 (2004), 451–463.
11. Asnagli, H., Martire, D., Belmonte, N., Quentin, J., Bastian, H., Boucard-Jourdin, M., Fall, P.B., Mausset-Bonnefont, A.L., Mantello-Moreau, A., Rouquier, S., et al. Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis. Arthritis Res. Ther., 16, 2014, R115.
12. Astier, A.L., Meiffren, G., Freeman, S., Hafler, D.A., Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 116 (2006), 3252–3257.
13. + Patients. AIDS Res. Hum. Retroviruses, 2018, 10.1089/AID.2018.0052 September 11, 2018.
14. Awasthi, A., Carrier, Y., Peron, J.P., Bettelli, E., Kamanaka, M., Flavell, R.A., Kuchroo, V.K., Oukka, M., Weiner, H.L., A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8 (2007), 1380–1389.
15. Bacchetta, R., de Waal Malefijt, R., Yssel, H., Abrams, J., de Vries, J.E., Spits, H., Roncarolo, M.G., Host-reactive CD4+ and CD8+ T cell clones isolated from a human chimera produce IL-5, IL-2, IFN-gamma and granulocyte/macrophage-colony-stimulating factor but not IL-4. J. Immunol. 144 (1990), 902–908.
16. Bacchetta, R., Bigler, M., Touraine, J.L., Parkman, R., Tovo, P.A., Abrams, J., de Waal Malefyt, R., de Vries, J.E., Roncarolo, M.G., High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med. 179 (1994), 493–502.
17. Bacchetta, R., Gregori, S., Serafini, G., Sartirana, C., Schulz, U., Zino, E., Tomiuk, S., Jansen, U., Ponzoni, M., Paties, C.T., et al. Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy. Haematologica 95 (2010), 2134–2143.
18. Bacchetta, R., Lucarelli, B., Sartirana, C., Gregori, S., Lupo Stanghellini, M.T., Miqueu, P., Tomiuk, S., Hernandez-Fuentes, M., Gianolini, M.E., Greco, R., et al. Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells. Front. Immunol., 5, 2014, 16.
19. Bacchetta, R., Barzaghi, F., Roncarolo, M.G., From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation. Ann. N Y Acad. Sci. 1417 (2018), 5–22.
20. Barrat, F.J., Cua, D.J., Boonstra, A., Richards, D.F., Crain, C., Savelkoul, H.F., de Waal-Malefyt, R., Coffman, R.L., Hawrylowicz, C.M., O'Garra, A., In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195 (2002), 603–616.
21. Battaglia, M., Stabilini, A., Draghici, E., Migliavacca, B., Gregori, S., Bonifacio, E., Roncarolo, M.G., Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes 55 (2006), 1571–1580.
22. Battaglia, M., Stabilini, A., Migliavacca, B., Horejs-Hoeck, J., Kaupper, T., Roncarolo, M.G., Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177 (2006), 8338–8347.
23. Batten, M., Kljavin, N.M., Li, J., Walter, M.J., de Sauvage, F.J., Ghilardi, N., Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J. Immunol. 180 (2008), 2752–2756.
24. Bergmann, C., Strauss, L., Wang, Y., Szczepanski, M.J., Lang, S., Johnson, J.T., Whiteside, T.L., T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease. Clin. Cancer Res. 14 (2008), 3706–3715.
25. Bollyky, P.L., Wu, R.P., Falk, B.A., Lord, J.D., Long, S.A., Preisinger, A., Teng, B., Holt, G.E., Standifer, N.E., Braun, K.R., et al. ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors. Proc. Natl. Acad. Sci. USA 108 (2011), 7938–7943.
26. Brockmann, L., Gagliani, N., Steglich, B., Giannou, A.D., Kempski, J., Pelczar, P., Geffken, M., Mfarrej, B., Huber, F., Herkel, J., et al. IL-10 Receptor Signaling Is Essential for TR1 Cell Function In Vivo. J. Immunol. 198 (2017), 1130–1141.
27. Brun, V., Bastian, H., Neveu, V., Foussat, A., Clinical grade production of IL-10 producing regulatory Tr1 lymphocytes for cell therapy of chronic inflammatory diseases. Int. Immunopharmacol. 9 (2009), 609–613.
28. Camisaschi, C., Casati, C., Rini, F., Perego, M., De Filippo, A., Triebel, F., Parmiani, G., Belli, F., Rivoltini, L., Castelli, C., LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites. J. Immunol. 184 (2010), 6545–6551.
29. Cardone, J., Le Friec, G., Vantourout, P., Roberts, A., Fuchs, A., Jackson, I., Suddason, T., Lord, G., Atkinson, J.P., Cope, A., et al. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat. Immunol. 11 (2010), 862–871.
30. Charbonnier, L.M., van Duivenvoorde, L.M., Apparailly, F., Cantos, C., Han, W.G., Noël, D., Duperray, C., Huizinga, T.W., Toes, R.E., Jorgensen, C., Louis-Plence, P., Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of CD49b+ regulatory T cells. J. Immunol. 177 (2006), 3806–3813.
31. Chen, C., Lee, W.H., Yun, P., Snow, P., Liu, C.P., Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes. J. Immunol. 171 (2003), 733–744.
32. Chen, Z.M., O'Shaughnessy, M.J., Gramaglia, I., Panoskaltsis-Mortari, A., Murphy, W.J., Narula, S., Roncarolo, M.G., Blazar, B.R., IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function. Blood 101 (2003), 5076–5083.
33. Chevalier, M.F., Didier, C., Petitjean, G., Karmochkine, M., Girard, P.M., Barré-Sinoussi, F., Scott-Algara, D., Weiss, L., Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells. J. Infect. Dis. 211 (2015), 769–779.
34. - Regulatory T Cells Induced by Repeated Stimulation of Antigen-Presenting B Cells. Sci. Rep., 7, 2017, 46348.
35. Chujo, D., Nguyen, T.S., Foucat, E., Blankenship, D., Banchereau, J., Nepom, G.T., Chaussabel, D., Ueno, H., Adult-onset type 1 diabetes patients display decreased IGRP-specific Tr1 cells in blood. Clin. Immunol. 161 (2015), 270–277.
36. Clemente-Casares, X., Blanco, J., Ambalavanan, P., Yamanouchi, J., Singha, S., Fandos, C., Tsai, S., Wang, J., Garabatos, N., Izquierdo, C., et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature 530 (2016), 434–440.
37. + T cells. Eur. J. Immunol. 43 (2013), 2730–2740.
38. de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M.G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., de Vries, J.E., Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174 (1991), 915–924.
39. Demeure, C.E., Wu, C.Y., Shu, U., Schneider, P.V., Heusser, C., Yssel, H., Delespesse, G., In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production. J. Immunol. 152 (1994), 4775–4782.
40. Dennis, K.L., Blatner, N.R., Gounari, F., Khazaie, K., Current status of interleukin-10 and regulatory T-cells in cancer. Curr. Opin. Oncol. 25 (2013), 637–645.
41. Desreumaux, P., Foussat, A., Allez, M., Beaugerie, L., Hebuterne, X., Bouhnik, Y., Nachury, M., Brun, V., Bastian, H., Belmonte, N., et al. Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. Gastroenterology 143 (2012), 1207–1217 e1201 1202.
42. Facciotti, F., Gagliani, N., Haringer, B., Alfen, J.S., Penatti, A., Maglie, S., Paroni, M., Iseppon, A., Moro, M., Crosti, M.C., et al. IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus. J Allergy Clin Immunol 137 (2016), 318–321 e315.
43. Farez, M.F., Mascanfroni, I.D., Méndez-Huergo, S.P., Yeste, A., Murugaiyan, G., Garo, L.P., Balbuena Aguirre, M.E., Patel, B., Ysrraelit, M.C., Zhu, C., et al. Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses. Cell 162 (2015), 1338–1352.
44. Fitzgerald, D.C., Zhang, G.X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C.J., Gran, B., Ciric, B., Rostami, A., Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8 (2007), 1372–1379.
45. Frenkel, D., Huang, Z., Maron, R., Koldzic, D.N., Hancock, W.W., Moskowitz, M.A., Weiner, H.L., Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells. J. Immunol. 171 (2003), 6549–6555.
46. Gagliani, N., Jofra, T., Stabilini, A., Valle, A., Atkinson, M., Roncarolo, M.G., Battaglia, M., Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant. Diabetes 59 (2010), 433–439.
47. Gagliani, N., Gregori, S., Jofra, T., Valle, A., Stabilini, A., Rothstein, D.M., Atkinson, M., Roncarolo, M.G., Battaglia, M., Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation. PLoS ONE, 6, 2011, e28434.
48. Gagliani, N., Jofra, T., Valle, A., Stabilini, A., Morsiani, C., Gregori, S., Deng, S., Rothstein, D.M., Atkinson, M., Kamanaka, M., et al. Transplant tolerance to pancreatic islets is initiated in the graft and sustained in the spleen. Am. J. Transplant. 13 (2013), 1963–1975.
49. Gagliani, N., Magnani, C.F., Huber, S., Gianolini, M.E., Pala, M., Licona-Limon, P., Guo, B., Herbert, D.R., Bulfone, A., Trentini, F., et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat. Med. 19 (2013), 739–746.
50. Gagliani, N., Amezcua Vesely, M.C., Iseppon, A., Brockmann, L., Xu, H., Palm, N.W., de Zoete, M.R., Licona-Limón, P., Paiva, R.S., Ching, T., et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523 (2015), 221–225.
51. Gianfrani, C., Levings, M.K., Sartirana, C., Mazzarella, G., Barba, G., Zanzi, D., Camarca, A., Iaquinto, G., Giardullo, N., Auricchio, S., et al. Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells. J. Immunol. 177 (2006), 4178–4186.
52. Głobińska, A., Boonpiyathad, T., Satitsuksanoa, P., Kleuskens, M., van de Veen, W., Sokolowska, M., Akdis, M., Mechanisms of allergen-specific immunotherapy: Diverse mechanisms of immune tolerance to allergens. Ann. Allergy Asthma Immunol. 121 (2018), 306–312.
53. Gregori, S., Roncarolo, M.G., Engineered T Regulatory Type 1 Cells for Clinical Application. Front. Immunol., 9, 2018, 233.
54. Gregori, S., Tomasoni, D., Pacciani, V., Scirpoli, M., Battaglia, M., Magnani, C.F., Hauben, E., Roncarolo, M.G., Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 116 (2010), 935–944.
55. Groux, H., Bigler, M., de Vries, J.E., Roncarolo, M.G., Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J. Exp. Med. 184 (1996), 19–29.
56. Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J.E., Roncarolo, M.G., A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 (1997), 737–742.
57. Groux, H., Bigler, M., de Vries, J.E., Roncarolo, M.G., Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J. Immunol. 160 (1998), 3188–3193.
58. Groux, H., Cottrez, F., Rouleau, M., Mauze, S., Antonenko, S., Hurst, S., McNeil, T., Bigler, M., Roncarolo, M.G., Coffman, R.L., A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J. Immunol. 162 (1999), 1723–1729.
59. Heinemann, C., Heink, S., Petermann, F., Vasanthakumar, A., Rothhammer, V., Doorduijn, E., Mitsdoerffer, M., Sie, C., Prazeres da Costa, O., Buch, T., et al. IL-27 and IL-12 oppose pro-inflammatory IL-23 in CD4+ T cells by inducing Blimp1. Nat. Commun., 5, 2014, 3770.
60. Hooper, K.M., Kong, W., Ganea, D., Prostaglandin E2 inhibits Tr1 cell differentiation through suppression of c-Maf. PLoS ONE, 12, 2017, e0179184.
61. Huang, W., Solouki, S., Koylass, N., Zheng, S.G., August, A., ITK signalling via the Ras/IRF4 pathway regulates the development and function of Tr1 cells. Nat. Commun., 8, 2017, 15871.
62. − and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 34 (2011), 554–565.
63. Ito, T., Hanabuchi, S., Wang, Y.H., Park, W.R., Arima, K., Bover, L., Qin, F.X., Gilliet, M., Liu, Y.J., Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 28 (2008), 870–880.
64. Iwasaki, Y., Fujio, K., Okamura, T., Yanai, A., Sumitomo, S., Shoda, H., Tamura, T., Yoshida, H., Charnay, P., Yamamoto, K., Egr-2 transcription factor is required for Blimp-1-mediated IL-10 production in IL-27-stimulated CD4+ T cells. Eur. J. Immunol. 43 (2013), 1063–1073.
65. Jeon, S.G., Kayama, H., Ueda, Y., Takahashi, T., Asahara, T., Tsuji, H., Tsuji, N.M., Kiyono, H., Ma, J.S., Kusu, T., et al. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog., 8, 2012, e1002714.
66. Jin, J.O., Han, X., Yu, Q., Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation. J. Autoimmun. 40 (2013), 28–44.
67. Jofra, T., Di Fonte, R., Galvani, G., Kuka, M., Iannacone, M., Battaglia, M., Fousteri, G., Tr1 cell immunotherapy promotes transplant tolerance via de novo Tr1 cell induction in mice and is safe and effective during acute viral infection. Eur. J. Immunol. 48 (2018), 1389–1399.
68. Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., Enk, A.H., Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192 (2000), 1213–1222.
69. Jutel, M., Akdis, C.A., Immunological mechanisms of allergen-specific immunotherapy. Allergy 66 (2011), 725–732.
70. Kamanaka, M., Kim, S.T., Wan, Y.Y., Sutterwala, F.S., Lara-Tejero, M., Galán, J.E., Harhaj, E., Flavell, R.A., Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25 (2006), 941–952.
71. Karwacz, K., Miraldi, E.R., Pokrovskii, M., Madi, A., Yosef, N., Wortman, I., Chen, X., Watters, A., Carriero, N., Awasthi, A., et al. Critical role of IRF1 and BATF in forming chromatin landscape during type 1 regulatory cell differentiation. Nat. Immunol. 18 (2017), 412–421.
72. Kemper, C., Chan, A.C., Green, J.M., Brett, K.A., Murphy, K.M., Atkinson, J.P., Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421 (2003), 388–392.
73. Kim, J., Lee, J., Gonzalez, J., Fuentes-Duculan, J., Garcet, S., Krueger, J.G., Proportion of CD4(+) CD49b(+) LAG-3(+) type 1 regulatory T cells in the blood of psoriasis patients inversely correlates with psoriasis area and severity index. J. Invest. Dermatol. 138 (2018), 2669–2672.
74. Koch, K., Koch, N., Sandaradura de Silva, U., Jung, N., Schulze zur Wiesch, J., Fätkenheuer, G., Hartmann, P., Romerio, F., Lehmann, C., Increased Frequency of CD49b/LAG-3(+) Type 1 Regulatory T Cells in HIV-Infected Individuals. AIDS Res. Hum. Retroviruses 31 (2015), 1238–1246.
75. Kunicki, M.A., Amaya Hernandez, L.C., Davis, K.L., Bacchetta, R., Roncarolo, M.G., Identity and Diversity of Human Peripheral Th and T Regulatory Cells Defined by Single-Cell Mass Cytometry. J. Immunol. 200 (2018), 336–346.
76. Lavasani, S., Dzhambazov, B., Nouri, M., Fåk, F., Buske, S., Molin, G., Thorlacius, H., Alenfall, J., Jeppsson, B., Weström, B., A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS ONE, 5, 2010, e9009.
77. Levings, M.K., Sangregorio, R., Galbiati, F., Squadrone, S., de Waal Malefyt, R., Roncarolo, M.G., IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166 (2001), 5530–5539.
78. Levings, M.K., Gregori, S., Tresoldi, E., Cazzaniga, S., Bonini, C., Roncarolo, M.G., Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 105 (2005), 1162–1169.
79. Lino, A.C., Dang, V.D., Lampropoulou, V., Welle, A., Joedicke, J., Pohar, J., Simon, Q., Thalmensi, J., Baures, A., Fluhler, V., et al. LAG-3 Inhibitory Receptor Expression Identifies Immunosuppressive Natural Regulatory Plasma Cells. Immunity 49 (2018), 120–133 e129.
80. + Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism. Mol. Ther. 25 (2017), 2254–2269.
81. Lönnberg, T., Svensson, V., James, K.R., Fernandez-Ruiz, D., Sebina, I., Montandon, R., Soon, M.S., Fogg, L.G., Nair, A.S., Liligeto, U., et al. Single-cell RNA-seq and computational analysis using temporal mixture modelling resolves Th1/Tfh fate bifurcation in malaria. Sci. Immunol., 2, 2017, eaal2192.
82. MacDonald, A.J., Duffy, M., Brady, M.T., McKiernan, S., Hall, W., Hegarty, J., Curry, M., Mills, K.H., CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J. Infect. Dis. 185 (2002), 720–727.
83. Magnani, C.F., Alberigo, G., Bacchetta, R., Serafini, G., Andreani, M., Roncarolo, M.G., Gregori, S., Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells. Eur. J. Immunol. 41 (2011), 1652–1662.
84. Mandapathil, M., Szczepanski, M.J., Szajnik, M., Ren, J., Jackson, E.K., Johnson, J.T., Gorelik, E., Lang, S., Whiteside, T.L., Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells. J. Biol. Chem. 285 (2010), 27571–27580.
85. Mascanfroni, I.D., Takenaka, M.C., Yeste, A., Patel, B., Wu, Y., Kenison, J.E., Siddiqui, S., Basso, A.S., Otterbein, L.E., Pardoll, D.M., et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α. Nat. Med. 21 (2015), 638–646.
86. Maynard, C.L., Harrington, L.E., Janowski, K.M., Oliver, J.R., Zindl, C.L., Rudensky, A.Y., Weaver, C.T., Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat. Immunol. 8 (2007), 931–941.
87. Meiler, F., Zumkehr, J., Klunker, S., Rückert, B., Akdis, C.A., Akdis, M., In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J. Exp. Med. 205 (2008), 2887–2898.
88. Meiron, M., Zohar, Y., Anunu, R., Wildbaum, G., Karin, N., CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells. J. Exp. Med. 205 (2008), 2643–2655.
89. Mfarrej, B., Tresoldi, E., Stabilini, A., Paganelli, A., Caldara, R., Secchi, A., Battaglia, M., Generation of donor-specific Tr1 cells to be used after kidney transplantation and definition of the timing of their in vivo infusion in the presence of immunosuppression. J. Transl. Med., 15, 2017, 40.
90. Miroux, C., Vausselin, T., Delhem, N., Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response. Expert Opin. Biol. Ther. 10 (2010), 1563–1572.
91. Montes de Oca, M., Kumar, R., de Labastida Rivera, F., Amante, F.H., Sheel, M., Faleiro, R.J., Bunn, P.T., Best, S.E., Beattie, L., Ng, S.S., et al. Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology. PLoS Pathog., 12, 2016, e1005398.
92. Morris, E.S., MacDonald, K.P., Rowe, V., Johnson, D.H., Banovic, T., Clouston, A.D., Hill, G.R., Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood 103 (2004), 3573–3581.
93. Murugaiyan, G., Mittal, A., Lopez-Diego, R., Maier, L.M., Anderson, D.E., Weiner, H.L., IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J. Immunol. 183 (2009), 2435–2443.
94. Neumann, C., Heinrich, F., Neumann, K., Junghans, V., Mashreghi, M.F., Ahlers, J., Janke, M., Rudolph, C., Mockel-Tenbrinck, N., Kühl, A.A., et al. Role of Blimp-1 in programing Th effector cells into IL-10 producers. J. Exp. Med. 211 (2014), 1807–1819.
95. Ni Choileain, S., Hay, J., Thomas, J., Williams, A., Vermeren, M.M., Benezech, C., Gomez-Salazar, M., Hugues, O.R., Vermeren, S., Howie, S.E.M., et al. TCR-stimulated changes in cell surface CD46 expression generate type 1 regulatory T cells. Sci. Signal., 10, 2017, eaah6163.
96. O'Garra, A., Vieira, P.L., Vieira, P., Goldfeld, A.E., IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J. Clin. Invest. 114 (2004), 1372–1378.
97. Okamura, T., Fujio, K., Shibuya, M., Sumitomo, S., Shoda, H., Sakaguchi, S., Yamamoto, K., CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2. Proc. Natl. Acad. Sci. USA 106 (2009), 13974–13979.
98. Okamura, T., Sumitomo, S., Morita, K., Iwasaki, Y., Inoue, M., Nakachi, S., Komai, T., Shoda, H., Miyazaki, J., Fujio, K., Yamamoto, K., TGF-β3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses. Nat. Commun., 6, 2015, 6329.
99. Pacciani, V., Gregori, S., Chini, L., Corrente, S., Chianca, M., Moschese, V., Rossi, P., Roncarolo, M.G., Angelini, F., Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites. J. Allergy Clin. Immunol. 125 (2010), 727–736.
100. Passerini, L., Di Nunzio, S., Gregori, S., Gambineri, E., Cecconi, M., Seidel, M.G., Cazzola, G., Perroni, L., Tommasini, A., Vignola, S., et al. Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome. Eur. J. Immunol. 41 (2011), 1120–1131.
101. Pedroza-Gonzalez, A., Zhou, G., Vargas-Mendez, E., Boor, P.P., Mancham, S., Verhoef, C., Polak, W.G., Grünhagen, D., Pan, Q., Janssen, H., et al. Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors. OncoImmunology, 4, 2015, e1008355.
102. Pellerin, L., Jenks, J.A., Chinthrajah, S., Dominguez, T., Block, W., Zhou, X., Noshirvan, A., Gregori, S., Roncarolo, M.G., Nadeau, K.C., Bacchetta, R., Peanut-specific type 1 regulatory T cells induced in vitro from allergic subjects are functionally impaired. J. Allergy Clin. Immunol., 2017, 141–202 213.
103. Petrelli, A., Tresoldi, E., Mfarrej, B.G., Paganelli, A., Spotti, D., Caldara, R., Secchi, A., Battaglia, M., Generation of Donor-specific T Regulatory Type 1 Cells From Patients on Dialysis for Cell Therapy After Kidney Transplantation. Transplantation 99 (2015), 1582–1589.
104. Petrich de Marquesini, L.G., Fu, J., Connor, K.J., Bishop, A.J., McLintock, N.E., Pope, C., Wong, F.S., Dayan, C.M., IFN-gamma and IL-10 islet-antigen-specific T cell responses in autoantibody-negative first-degree relatives of patients with type 1 diabetes. Diabetologia 53 (2010), 1451–1460.
105. Pot, C., Jin, H., Awasthi, A., Liu, S.M., Lai, C.Y., Madan, R., Sharpe, A.H., Karp, C.L., Miaw, S.C., Ho, I.C., Kuchroo, V.K., Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183 (2009), 797–801.
106. Quintana, F.J., Basso, A.S., Iglesias, A.H., Korn, T., Farez, M.F., Bettelli, E., Caccamo, M., Oukka, M., Weiner, H.L., Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453 (2008), 65–71.
107. Rahmoun, M., Foussat, A., Groux, H., Pène, J., Yssel, H., Chanez, P., Enhanced frequency of CD18- and CD49b-expressing T cells in peripheral blood of asthmatic patients correlates with disease severity. Int. Arch. Allergy Immunol. 140 (2006), 139–149.
108. Ranjbar, M., Solgi, G., Mohammadnia, M., Nikbin, B., Pourmand, G., Ansaripour, B., Amirzargar, A., Regulatory T-cell subset analysis and profile of interleukin (IL)-10, IL-17 and interferon-gamma cytokine-producing cells in kidney allograft recipients with donor cells infusion. Â. Clin. Exp. Nephrol 16 (2012), 636–646.
109. Roncarolo, M.G., Yssel, H., Touraine, J.L., Betuel, H., De Vries, J.E., Spits, H., Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera. J. Exp. Med. 167 (1988), 1523–1534.
110. Roncarolo, M.G., Gregori, S., Bacchetta, R., Battaglia, M., Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications. Curr. Top. Microbiol. Immunol. 380 (2014), 39–68.
111. Rouse, B.T., Sehrawat, S., Immunity and immunopathology to viruses: What decides the outcome?. Nat. Rev. Immunol. 10 (2010), 514–526.
112. Sabatos-Peyton, C.A., Verhagen, J., Wraith, D.C., Antigen-specific immunotherapy of autoimmune and allergic diseases. Curr. Opin. Immunol. 22 (2010), 609–615.
113. Said, S.S., Barut, G.T., Mansur, N., Korkmaz, A., Sayi-Yazgan, A., Bacterially activated B-cells drive T cell differentiation towards Tr1 through PD-1/PD-L1 expression. Mol. Immunol. 96 (2018), 48–60.
114. Sanda, S., Roep, B.O., von Herrath, M., Islet antigen specific IL-10+ immune responses but not CD4+CD25+FoxP3+ cells at diagnosis predict glycemic control in type 1 diabetes. Clin. Immunol. 127 (2008), 138–143.
115. Schultz-Cherry, S., Hinshaw, V.S., Influenza virus neuraminidase activates latent transforming growth factor beta. J. Virol. 70 (1996), 8624–8629.
116. + regulatory T cells. Mucosal Immunol. 7 (2014), 428–439.
117. Serafini, G., Andreani, M., Testi, M., Battarra, M., Bontadini, A., Biral, E., Fleischhauer, K., Marktel, S., Lucarelli, G., Roncarolo, M.G., Bacchetta, R., Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia. Haematologica 94 (2009), 1415–1426.
118. Singha, S., Shao, K., Yang, Y., Clemente-Casares, X., Solé P., Clemente, A., Blanco, J., Dai, Q., Song, F., Liu, S.W., et al. Peptide-MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices. Nat. Nanotechnol. 12 (2017), 701–710.
119. Smith, E.L., Peakman, M., Peptide Immunotherapy for Type 1 Diabetes-Clinical Advances. Front. Immunol., 9, 2018, 392.
120. Song, Z., Zhang, T., Li, G., Tang, Y., Luo, Y., Yu, G., Tr1 responses are elevated in asymptomatic H. pylori-infected individuals and are functionally impaired in H. pylori-gastric cancer patients. Exp. Cell Res. 367 (2018), 251–256.
121. Steinbrink, K., Wölfl, M., Jonuleit, H., Knop, J., Enk, A.H., Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159 (1997), 4772–4780.
122. Steinbrink, K., Graulich, E., Kubsch, S., Knop, J., Enk, A.H., CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 99 (2002), 2468–2476.
123. Stumhofer, J.S., Silver, J.S., Laurence, A., Porrett, P.M., Harris, T.H., Turka, L.A., Ernst, M., Saris, C.J., O'Shea, J.J., Hunter, C.A., Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8 (2007), 1363–1371.
124. Sumitomo, S., Yamamoto, K., CD4+CD25-LAG-3+ T cells in mouse and human. Nihon Rinsho Meneki Gakkai Kaishi 33 (2010), 92–98.
125. Sutavani, R.V., Bradley, R.G., Ramage, J.M., Jackson, A.M., Durrant, L.G., Spendlove, I., CD55 costimulation induces differentiation of a discrete T regulatory type 1 cell population with a stable phenotype. J. Immunol. 191 (2013), 5895–5903.
126. Totsuka, T., Kanai, T., Makita, S., Fujii, R., Nemoto, Y., Oshima, S., Okamoto, R., Koyanagi, A., Akiba, H., Okumura, K., et al. Regulation of murine chronic colitis by CD4+CD25- programmed death-1+ T cells. Eur. J. Immunol. 35 (2005), 1773–1785.
127. Tousa, S., Semitekolou, M., Morianos, I., Banos, A., Trochoutsou, A.I., Brodie, T.M., Poulos, N., Samitas, K., Kapasa, M., Konstantopoulos, D., et al. Activin-A co-opts IRF4 and AhR signaling to induce human regulatory T cells that restrain asthmatic responses. Proc. Natl. Acad. Sci. USA 114 (2017), E2891–E2900.
128. Tree, T.I., Lawson, J., Edwards, H., Skowera, A., Arif, S., Roep, B.O., Peakman, M., Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppression. Diabetes 59 (2010), 1451–1460.
129. van den Boogaardt, D.E., van Miert, P.P., de Vaal, Y.J., de Fijter, J.W., Claas, F.H., Roelen, D.L., The ratio of interferon-γ and interleukin-10 producing donor-specific cells as an in vitro monitoring tool for renal transplant patients. Transplantation 82 (2006), 844–848.
130. Vicente, R., Quentin, J., Mausset-Bonnefont, A.L., Chuchana, P., Martire, D., Cren, M., Jorgensen, C., Louis-Plence, P., Nonclassical CD4+CD49b+ Regulatory T Cells as a Better Alternative to Conventional CD4+CD25+ T Cells To Dampen Arthritis Severity. J. Immunol. 196 (2016), 298–309.
131. Vieira, P., de Waal-Malefyt, R., Dang, M.N., Johnson, K.E., Kastelein, R., Fiorentino, D.F., deVries, J.E., Roncarolo, M.G., Mosmann, T.R., Moore, K.W., Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. USA 88 (1991), 1172–1176.
132. Wakkach, A., Cottrez, F., Groux, H., Differentiation of regulatory T cells 1 is induced by CD2 costimulation. J. Immunol. 167 (2001), 3107–3113.
133. Wakkach, A., Fournier, N., Brun, V., Breittmayer, J.P., Cottrez, F., Groux, H., Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18 (2003), 605–617.
134. Wang, H., Meng, R., Li, Z., Yang, B., Liu, Y., Huang, F., Zhang, J., Chen, H., Wu, C., IL-27 induces the differentiation of Tr1-like cells from human naive CD4+ T cells via the phosphorylation of STAT1 and STAT3. Immunol. Lett. 136 (2011), 21–28.
135. White, A.M., Wraith, D.C., Tr1-Like T Cells - An Enigmatic Regulatory T Cell Lineage. Front. Immunol., 7, 2016, 355.
136. Wildbaum, G., Netzer, N., Karin, N., Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading. J. Clin. Invest. 110 (2002), 701–710.
137. Xu, L., Yin, W., Sun, R., Wei, H., Tian, Z., Liver type I regulatory T cells suppress germinal center formation in HBV-tolerant mice. Proc. Natl. Acad. Sci. USA 110 (2013), 16993–16998.
138. Xu, Y.Q., Gao, Y.D., Yang, J., Guo, W., A defect of CD4+CD25+ regulatory T cells in inducing interleukin-10 production from CD4+ T cells under CD46 costimulation in asthma patients. J Asthma 47 (2010), 367–373.
139. Yan, H., Zhang, P., Kong, X., Hou, X., Zhao, L., Li, T., Yuan, X., Fu, H., Primary Tr1 cells from metastatic melanoma eliminate tumor-promoting macrophages through granzyme B- and perforin-dependent mechanisms. Tumour Biol. 39 (2017), 1–8.
140. Yao, Y., Vent-Schmidt, J., McGeough, M.D., Wong, M., Hoffman, H.M., Steiner, T.S., Levings, M.K., Tr1 Cells, but Not Foxp3+ Regulatory T Cells, Suppress NLRP3 Inflammasome Activation via an IL-10-Dependent Mechanism. J. Immunol. 195 (2015), 488–497.
141. Yu, H., Gagliani, N., Ishigame, H., Huber, S., Zhu, S., Esplugues, E., Herold, K.C., Wen, L., Flavell, R.A., Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development. Proc. Natl. Acad. Sci. USA 114 (2017), 10443–10448.
142. Zeller, J.C., Panoskaltsis-Mortari, A., Murphy, W.J., Ruscetti, F.W., Narula, S., Roncarolo, M.G., Blazar, B.R., Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta. J. Immunol. 163 (1999), 3684–3691.
143. R1) cells. Sci. Immunol., 2, 2017, 10.1126/sciimmunol.aah7152 Published April 7, 2017.
144. Zheng, Y., Josefowicz, S., Chaudhry, A., Peng, X.P., Forbush, K., Rudensky, A.Y., Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463 (2010), 808–812.
145. Zhu, Z., Ye, J., Ma, Y., Hua, P., Huang, Y., Fu, X., Li, D., Yuan, M., Xia, Z., Function of T regulatory type 1 cells is down-regulated and is associated with the clinical presentation of coronary artery disease. Hum. Immunol. 79 (2018), 564–570.